Neuropace Stock In The News
| NPCE Stock | USD 10.25 0.05 0.49% |
Our overall analysis of Neuropace's news coverage and content from conventional and social sources shows investors' bearish mood towards Neuropace. The specific impact of Neuropace news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Neuropace's overall financial health and prospects. It also depends on the type and quality of a news publisher.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Neuropace headlines in addition to utilizing other, more conventional financial analysis modules. Check out Neuropace Backtesting and Neuropace Hype Analysis. For information on how to trade Neuropace Stock refer to our How to Trade Neuropace Stock guide.
Neuropace |
Neuropace Today Top News and Investor Outlook
Neuropace Past News Timeline
Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Neuropace and other traded companies coverage with news coverage. We help investors stay connected with Neuropace headlines for the 28th of November to make an informed investment decision based on correlating the impacts of news items on Neuropace Stock performance. Please note that trading solely based on the Neuropace hype is not for everyone as timely availability and quick action are needed to avoid losses.
Neuropace stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Neuropace earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Neuropace that are available to investors today. That information is available publicly through Neuropace media outlets and privately through word of mouth or via Neuropace internal channels. However, regardless of the origin, that massive amount of Neuropace data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Neuropace news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Neuropace relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Neuropace's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Neuropace alpha.
Neuropace Largest EPS Surprises
Earnings surprises can significantly impact Neuropace's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2024-08-13 | 2024-06-30 | -0.3 | -0.26 | 0.04 | 13 | ||
2021-11-10 | 2021-09-30 | -0.3 | -0.34 | -0.04 | 13 | ||
2023-05-04 | 2023-03-31 | -0.46 | -0.41 | 0.05 | 10 | ||
2024-11-12 | 2024-09-30 | -0.27 | -0.19 | 0.08 | 29 | ||
2024-03-05 | 2023-12-31 | -0.31 | -0.23 | 0.08 | 25 | ||
2022-08-11 | 2022-06-30 | -0.44 | -0.52 | -0.08 | 18 |
Neuropace Stock Latest Headlines
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Neuropace Stock. The global stock market is bearish. About 62% of major world exchanges and indexes are down. See today's market update for more information.
25th of November 2024
NeuroPaces SWOT analysis epilepsy device makers stock poised for growth at investing.com
19th of November 2024
Page 89 Impact Investing - Equities News at news.google.com
13th of November 2024
NeuroPace Inc Q3 2024 Earnings Call Highlights Record Revenue and Strategic Growth ... at gurufocus.com
11th of November 2024
Earnings To Watch NeuroPace Inc Reports Q3 2024 Result at gurufocus.com
4th of November 2024
NeuroPace Announces FDA Submission of Three-Year Data from Post-Approval Study of the RNS ... at globenewswire.com
28th of October 2024
Neuropace shareholder KCK Ltd. sells 1.22 million in stock at investing.com
23rd of October 2024
Disposition of 147 shares by Kck Ltd. of Neuropace at 6.02 subject to Rule 16b-3 at MacroaxisInsider
22nd of October 2024
Disposition of 4082 shares by Kck Ltd. of Neuropace at 6.0885 subject to Rule 16b-3 at finance.yahoo.com
9th of October 2024
Disposition of 3123 shares by Kck Ltd. of Neuropace at 6.1048 subject to Rule 16b-3 at MacroaxisInsider
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Neuropace in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Neuropace's short interest history, or implied volatility extrapolated from Neuropace options trading.
Check out Neuropace Backtesting and Neuropace Hype Analysis. For information on how to trade Neuropace Stock refer to our How to Trade Neuropace Stock guide.You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Neuropace. If investors know Neuropace will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Neuropace listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.98) | Revenue Per Share 2.697 | Quarterly Revenue Growth 0.282 | Return On Assets (0.15) | Return On Equity (2.15) |
The market value of Neuropace is measured differently than its book value, which is the value of Neuropace that is recorded on the company's balance sheet. Investors also form their own opinion of Neuropace's value that differs from its market value or its book value, called intrinsic value, which is Neuropace's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Neuropace's market value can be influenced by many factors that don't directly affect Neuropace's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Neuropace's value and its price as these two are different measures arrived at by different means. Investors typically determine if Neuropace is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Neuropace's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.